(Q47987708)

7 February 2018

title

MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain (English)

1 reference

7 February 2018

1 reference

1 reference

4

1 reference

7 February 2018

author name string

Bertorelli R

series ordinal

1

1 reference

7 February 2018

Adami M

series ordinal

2

1 reference

7 February 2018

Di Santo E

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

7 February 2018

published in

Neuroscience Letters

1 reference

7 February 2018

volume

246

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

41-44

1 reference

7 February 2018

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Dexamethasone as Treatment in Cerebrovascular Disease. 2. A Controlled Study in Acute Cerebral Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Differential temporal patterns of expression of immediate early genes in cerebral cortex induced by intracerebral excitotoxin injection: sensitivity to dexamethasone and MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Tumor necrosis factor-alpha expression in ischemic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

High dose steroid treatment in cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900221-3

7 January 2021

10.1016/S0304-3940(98)00221-3

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018